2022 ASCO Annual Meeting
June 3-7 | Join us at booth 3135 in Chicago at the 2022 ASCO Annual Meeting and Expo.
- Category:
- Past Events
News & Events
ESHG Conference 2022
JUNE 11–14, 2022 | Join us at the European Human Genetics Conference in Vienna
- Category:
- Past Events
ABRF 2022 Annual Meeting
March 27-30 | Join us at the ABRF Annual Meeting in Palm Springs, CA
- Category:
- Past Events
74th Annual AAFS 2022 Annual Scientific Conference
February 21-25 | Join us at the annual conference to learn more about the exciting new advances in NGS and forensic science.
- Category:
- Past Events
16th International Virtual Conference on Malignant Lymphoma
June 18 - 22, 2021| Join us at this international congress to learn more about the latest advances in the science regarding malignant lymphoma.
- Category:
- Past Events
2021 ASCO Virtual Scientific Meeting
June 4 - 8, 2021 | Join us at ASCO and learn about breakthrough research being presented by HTG customers.
- Category:
- Past Events
Nature Research Custom Media webcast: A comparison of gene expression technologies in clinical applications
Dr. Kerry Culm-Merdek of Oncologie and Dr. Marian Navratil of HTG Molecular Diagnostics will describe their cross-platform comparison study between RNA-Seq and HTG’s translational research profiling panel, the HTG EdgeSeq Precision Immuno-Oncology Panel (PIP) for measuring gene expression.
- Category:
- Past Events
AACR Virtual Meeting II Poster Session
EMD Serono’s Dr. O’Rourke, et. al. presents comparison of
HTG EdgeSeq technology
- Category:
- Past Events
ASCO 2020 Virtual Scientific Meeting Poster Session
Platform comparison of HTG EdgeSeq and RNA-Seq for gene expression profiling of tumor tissue specimens.
- Category:
- Past Events
LinkedIn Webinar: New end-user bioinformatics pipeline for patient stratification in precision medicine
Virtual Podium presentation by Dr. James Cooley. Register now!
- Category:
- Past Events
USCAP 2020 Customer Presentation by Dr. Leonie AS Frauenfeld
Presentation Background: Diffuse large B-cell lymphoma (DLBCL) is the most common NHL in adults. Gene expression profiling (GEP) divides DLBCL according to the cell of origin (COO) into three subgroups: GCB, ABC and unclassifiable (UNC), exhibiting different mutational profiles.
- Category:
- Past Events
Page last updated April 29, 2022